Search Results: N10-008 PrüfungGuide, CompTIA N10-008 Zertifikat - CompTIA Network+ Certification Exam 🔨 Suchen Sie einfach auf 【 www.itzert.com 】 nach kostenloser Download von ➽ N10-008 🢪 ❣N10-008 Deutsch Prüfung

Clinical Research Newsletter

12/29/2020

Register For Our Newsletter and Never Miss An Update! Don’t Miss A Single Update! Once a month we release our newsletter where we share with you all of the latest news and updates regarding TrialStat, as well as our ever evolving industry! We’d love to have you register and become a part of our growing…

Read More

Resilience and MD Anderson Launch Joint Venture to Accelerate Development and Manufacturing of Innovative Cell Therapies for Cancer

06/14/2022

Excerpt from the Press Release: SAN DIEGO & HOUSTON–(BUSINESS WIRE)–National Resilience, Inc. (Resilience) and The University of Texas MD Anderson Cancer Center today announced the launch of a joint venture, the Cell Therapy Manufacturing Center, to accelerate the development and manufacturing of innovative cell therapies for patients with cancer. Uniting the strengths of Resilience and…

Read More

Ask Us Anything In Clinical Research – 2021 Life Sciences Business Development & Marketing Strategies

01/28/2021

On January 21st, we held our first Ask Us Anything in Clinical Research Virtual networking meeting for the new year! Heather and I were joined by our guest speaker, Pearl Mensah of Pilatus Comparator Solutions for this exciting meeting. We’ve had 10 months of experience marketing and selling remotely. We’ve seen what worked, and what’s…

Read More

Focused Ultrasound for Parkinson’s Disease: Results of First Clinical Trial to Deliver Therapeutics

10/06/2022

Key Points The results of an early-stage clinical trial investigating focused ultrasound to address a possible underlying cause of Parkinson’s disease were published in Movement Disorders. Researchers in Toronto tested the safety and efficacy of focused ultrasound–induced blood-brain barrier opening to deliver enzyme replacement therapy. The procedure was well-tolerated, and a larger study is being…

Read More

COTA and MedStar Health Partner To Drive Scientific Research and Expedite Delivery of Innovative Cancer Treatments

07/22/2021

Excerpt from the Press Release: BOSTON, July 15, 2021 /PRNewswire/ — COTA, Inc., an oncology real-world data and analytics company, announced a new research partnership with MedStar Health. COTA will support MedStar Health in its use of real-world data to accelerate scientific discovery and improve care for cancer patients. MedStar Health is the largest healthcare provider in the Maryland and Washington, D.C.,…

Read More

Iterative Scopes and Crohn’s & Colitis Foundation Announce Partnership to Advance Next-Generation IBD Treatment

09/30/2021

Access to the Foundation’s unparalleled patient data repository will enrich company’s computational endoscopic approaches to biopharmaceutical research and clinical care for IBD CAMBRIDGE, Mass.–(BUSINESS WIRE)–Iterative Scopes, a pioneer in the development of precision-based technologies for treating gastrointestinal diseases, announced today that it has entered into an AI-powered diagnostic tools partnership with the Crohns & Colitis…

Read More

Compass Therapeutics Announces that the Phase 2 Data of CTX-009 in Combination with Paclitaxel in Patients with Biliary Tract Cancers (BTC) will be Presented at the ASCO GI Cancers Symposium on January 20, 2023

01/23/2023

Compass to Host Investor Event on Monday, January 23rd at 8:30am ET Excerpt from the Press Release: BOSTON, Jan. 19, 2023 (GLOBE NEWSWIRE) — Compass Therapeutics, Inc. (Nasdaq: CMPX), a clinical-stage, oncology-focused biopharmaceutical company developing proprietary antibody-based therapeutics to treat multiple human diseases, today announced the presentation of data from a Phase 2 study of…

Read More

BeiGene Announces New Efficacy Analysis Comparing BRUKINSA® vs Acalabrutinib in Relapsed or Refractory Chronic Lymphocytic Leukemia

03/06/2024

Matching adjusted indirect comparison addresses key questions and limitations associated with previously presented analysis and suggests efficacy advantage of BRUKINSA vs acalabrutinib Excerpt from the Press Release: BASEL, Switzerland & BEIJING & CAMBRIDGE, Mass.–(BUSINESS WIRE)–BeiGene, Ltd. (Nasdaq: BGNE; HKEX: 06160; SSE: 688235), a global oncology company, today announced a new matching adjusted indirect comparison (MAIC)…

Read More

HeartBeam Partners with Phoebe Putney Health System for First Pilot Study of Emergency Department Myocardial Infarction Software

03/10/2022

Business Associate Agreement and Clinical Trial Agreement with Additional Planned Studies and Commercial and Scientific Collaboration Excerpt from the Press Release: SANTA CLARA, Calif.–(BUSINESS WIRE)–HeartBeam, Inc. (NASDAQ: BEAT), a developmental stage digital healthcare company with a proprietary ECG telemedicine technology for heart attack detection, today announced it has signed a Business Associate Agreement (BAA) and Clinical…

Read More

Chest X-ray Plus Artificial Intelligence Can Predict Worst Outcomes for COVID-19-Positive Patients

05/17/2021

Excerpt from the Press Release: Computer program can accurately predict 80 percent of cases where COVID-19 patients will develop life-threatening conditions within four days. Chest X-rays aren’t just for diagnosing COVID-19. Newly published research now shows that these images can be part of a system that accurately predicts which patients will develop life-threatening conditions within…

Read More